sitagliptin and metformin

DRUG3 trials

Sponsors

Hadassah Medical Organization, University Medical Centre Ljubljana, Shanghai 10th People's Hospital

Conditions

Body WeightDiabetes MellitusGastroduodenal UlcerIron Metabolism DisordersNAFLDOptic AtrophyPlatelet DysfunctionPolycystic Ovary Syndrome

Phase 2

Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy

Hadassah Medical OrganizationDiabetes Mellitus, Gastroduodenal Ulcer, Iron Metabolism Disorders +3

Start: 2016-12-31End: 2018-12-31Target: 20Updated: 2016-08-29

Phase 4

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

CompletedNCT02941445

University Medical Centre LjubljanaBody Weight, Polycystic Ovary Syndrome

Start: 2015-10-31End: 2016-08-31Updated: 2016-10-21

Unknown Phase

Non-alcoholic Fatty Liver Disease and Its Treatment

CompletedNCT05480007

Shanghai 10th People's HospitalNAFLD

Start: 2011-01-30End: 2018-12-01Updated: 2022-07-29

Related Papers

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease

Frontiers in Endocrinology2022-08-2222 citations